Isolation of Trypanosoma brucei gambiense from Cured and Relapsed Sleeping Sickness Patients and Adaptation to Laboratory Mice

BACKGROUND: Sleeping sickness due to Trypanosoma brucei (T.b.) gambiense is still a major public health problem in some central African countries. Historically, relapse rates around 5% have been observed for treatment with melarsoprol, widely used to treat second stage patients. Later, relapse rates...

Descripción completa

Detalles Bibliográficos
Autores principales: Pyana, Patient Pati, Ngay Lukusa, Ipos, Mumba Ngoyi, Dieudonné, Van Reet, Nick, Kaiser, Marcel, Karhemere Bin Shamamba, Stomy, Büscher, Philippe
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3079580/
https://www.ncbi.nlm.nih.gov/pubmed/21526217
http://dx.doi.org/10.1371/journal.pntd.0001025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3079580/
https://www.ncbi.nlm.nih.gov/pubmed/21526217
http://dx.doi.org/10.1371/journal.pntd.0001025

Ejemplares similares